Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples